Swedencare reports Q2 revenue of SEK 646.7 million, organic growth at 7%

Swedencare AB (STO:SECARE) reported mixed second-quarter results with revenue of SEK 646.7 million, a net loss of SEK 6.9 million (EPS SEK -0.04), and adjusted EBITDA down 13% year-over-year to SEK 122.9 million. Organic growth reached 7%, improving sequentially but still below target, while currency fluctuations negatively impacted results by 8%. Looking ahead, the pet health company plans to pivot its merger and acquisition strategy towards geographical expansion, specifically targeting new markets in Asia such as China and India.

Analysis

Swedencare AB (STO:SECARE) reported mixed second-quarter results, characterized by a profitability decline despite some underlying growth. The company generated SEK 646.7 million in revenue but posted a net loss of SEK 6.9 million (EPS of SEK -0.04). A key point of concern is the 13% year-over-year decrease in adjusted EBITDA to SEK 122.9 million, indicating significant margin pressure. While organic growth reached 7%, showing a sequential improvement, it remained below the company's internal targets. Furthermore, performance was materially impacted by an 8% negative headwind from currency fluctuations, obscuring the underlying operational results. In response to this environment, management is pivoting its M&A strategy away from its previous focus towards geographical expansion, specifically targeting high-growth Asian markets like China and India. This signals a long-term strategic shift to capture new revenue streams, though it introduces new market entry risks.

Key Decisions for Investors

• Investors should scrutinize future earnings reports for margin recovery, as the 13% decline in adjusted EBITDA and the net loss currently overshadow the positive 7% organic growth.
• The strategic pivot to Asian markets introduces a long-term growth catalyst but also significant execution risk; monitor for specific announcements on partnerships or market entry progress before pricing in this potential.
• Given the substantial 8% negative impact from currency movements, consider the ongoing foreign exchange risk as a key factor in performance, particularly for portfolios sensitive to currency volatility.